Medications for IBS with Constipation (IBS-C)
Linaclotide is the most efficacious first-line secretagogue for IBS-C, though diarrhea is a common side effect. 1
First-Line Treatment Options
Osmotic Laxatives
- Polyethylene glycol (PEG) laxatives are suggested as a first-line treatment for IBS-C, with low to moderate certainty of evidence 2
- PEG works as an osmotic laxative that increases stool frequency, though evidence for improvement in abdominal pain is limited 2
- Common side effects include bloating, abdominal discomfort, and cramping 3
Soluble Fiber
- Soluble fiber such as ispaghula is effective for global symptoms and abdominal pain in IBS-C 1
- Should be started at a low dose (3-4 g/day) and gradually increased to avoid bloating 1
- Insoluble fiber (e.g., wheat bran) should be avoided as it may worsen symptoms 1
Second-Line Treatment Options
Secretagogues
Linaclotide
- Guanylate cyclase-C agonist that is FDA-approved for IBS-C in adults 4
- Recommended dose for IBS-C: 290 mcg orally once daily on an empty stomach, at least 30 minutes before a meal 4
- Strong recommendation with high-quality evidence 1
- Most efficacious secretagogue available for IBS-C, though diarrhea is a common side effect 1
- Take on an empty stomach at approximately the same time each day 4
Lubiprostone
- Chloride channel type 2 activator that increases chloride influx into the intestinal lumen, accelerating intestinal transit 2
- FDA-approved for women with IBS-C at a dosage of 8 mcg twice daily 2, 5
- Strong recommendation with moderate-quality evidence 1
- Less likely to cause diarrhea than other secretagogues, but nausea is a frequent side effect 1
- Shown to be well-tolerated for up to 13 months of treatment 2, 6
Plecanatide
- Another guanylate cyclase-C agonist approved for IBS-C 1
- Weak recommendation with very low-quality evidence 1
- Diarrhea is a common side effect 1
- FDA-approved in the USA but may not be available in all countries 1
Tenapanor
- Sodium-hydrogen exchange inhibitor effective for IBS-C 1
- Strong recommendation with high-quality evidence 1
- Diarrhea is a frequent side effect 1
- FDA-approved in the USA but may not be available in all countries 1
Tegaserod
- 5-Hydroxytryptamine 4 receptor agonist effective for IBS-C 1
- Strong recommendation with moderate-quality evidence 1
- Only available in the USA and restricted to women under 65 years without cardiovascular risk factors 1, 2
- Diarrhea is a common side effect 1
Neuromodulators for IBS-C with Significant Pain
- Tricyclic antidepressants (TCAs) are effective second-line drugs for global symptoms and abdominal pain 1
- Start at a low dose (e.g., amitriptyline 10 mg once daily) and titrate slowly to 30-50 mg once daily 1
- Strong recommendation with moderate-quality evidence 1
- Selective serotonin reuptake inhibitors (SSRIs) may be effective for global symptoms 1
- Weak recommendation with low-quality evidence 1
Treatment Algorithm
Initial approach:
If inadequate response:
For refractory symptoms:
Important Considerations
- Medication choice should be guided by symptom severity, predominant symptoms, and potential side effect profiles 7, 8
- Secretagogues (linaclotide, lubiprostone) have different mechanisms of action and side effect profiles, allowing for tailored therapy 9, 10
- Patients should be warned about potential side effects - diarrhea with linaclotide and tenapanor; nausea with lubiprostone 1
- Most medications for IBS-C improve both bowel habits and abdominal pain, though to varying degrees 9
- Long-term safety has been established for lubiprostone (up to 13 months) 6 and should be considered for chronic therapy